Market by Product, Application, Source Type, and Country | Forecast 2021-2028
Triton’s research report insinuates that the North America biosurgery market is anticipated to observe growth at a CAGR of 5.30% during the forecasted years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries discussed in
this market are:
• United States
• Canada
The region’s growth can be attributed
to the rising aging population, growth in the prevalence of chronic diseases,
especially cardiovascular and cancer, technological advancements, and rising
government investments. In the US, the biosurgery market is anticipated to
witness rapid growth, owing to the rise in research and development activities
relating to biosurgery products.
Furthermore, the high
prevalence of cardiovascular diseases has increased the number of surgeries, in
turn increasing the use of biosurgery products across the country. Over the
years, the number of minimally-invasive cosmetic procedures has gained traction
across the country, supporting the adoption of biosurgery products. Hence, such
developments are likely to stimulate the growth of the biosurgery market within
the US.
Similarly, the biosurgery
market is anticipated to witness tremendous growth owing to the rise in the
number of surgical procedures, surge in chronic diseases, and growing geriatric
population across Canada. As per the Canadian Institute for Health Information
2020 report, a significant number of hip and knee replacement surgeries were
performed in the past few years. This increase in various surgical procedures
amplifies the adoption rate of biosurgery products across the country.
Therefore, all these factors hold the potential to widen the growth of the
biosurgery market within Canada over the upcoming years.
RTI Surgical is a surgical
implant company engaged in the development and sales of biologic, metal, and
synthetic implants. The company’s products include spine implants, sports
medicine implants, surgical specialties, and others. The company processes
tissue at two facilities based in Florida and Germany and develops metal and
synthetic implants in Michigan. It is headquartered in the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA BIOSURGERY MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON BIOSURGERY MARKET
2.2. TRENDS
IN BIOSURGERY TECHNOLOGY
2.3. KEY
INSIGHTS
2.4. PORTER’S
FIVE FORCES MODEL
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE PRODUCTS
2.4.3. BARGAINING
POWER OF BUYERS
2.4.4. BARGAINING
POWER OF SUPPLIERS
2.4.5. COMPETITIVE
RIVALRY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
BUYING OUTLOOK
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGING POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES
2.9.3. SURGE
IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.9.4. PREVALENCE
OF SPINAL FUSION AND JOINT RECONSTRUCTION
2.9.5. STRONG
FOCUS ON RESEARCH AND DEVELOPMENT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SURGERIES
2.10.2. COMPLICATIONS
RELATED TO IMMUNE RESPONSE
2.10.3. USAGE
OF MINIMALLY INVASIVE SURGERIES
2.11. MARKET
OPPORTUNITIES
2.11.1. RESEARCH
AND INVESTMENTS IN BIOENGINEERING
2.11.2. DEVELOPMENT
OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. NORTH
AMERICA BIOSURGERY MARKET – BY PRODUCT
3.1. HEMOSTATIC
AGENTS
3.2. BONE-GRAFT
SUBSTITUTES
3.2.1. SYNTHETIC
GRAFT EXTENDERS
3.2.2. DEMINERALIZED
BONE MATRIX
3.2.3. BONE
MORPHOGENETIC PROTEINS
3.2.4. CELL-BASED
MATRICES
3.3. SURGICAL
SEALING AGENTS
3.3.1. NATURAL
3.3.2. SYNTHETIC
3.4. SOFT-TISSUE
MANAGEMENT
3.4.1. SYNTHETIC
MESH/PATCH
3.4.2. NATURAL
MESH/PATCH
3.5. ANTI-ADHESIVE
AGENTS
3.6. STAPLE
LINE REINFORCEMENT
4. NORTH
AMERICA BIOSURGERY MARKET – BY APPLICATION
4.1. ORTHOPEDIC
SURGERY
4.2. CARDIO
AND THORACIC SURGERY
4.3. NEURO
AND SPINE SURGERY
4.4. GENERAL
SURGERY
4.5. OTHER
APPLICATIONS
5. NORTH
AMERICA BIOSURGERY MARKET – BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. NORTH
AMERICA BIOSURGERY MARKET – COUNTRY OUTLOOK
6.1. COUNTRY
ANALYSIS
6.1.1. UNITED
STATES
6.1.2. CANADA
7. COMPETITIVE
LANDSCAPE
7.1. BAXTER
INTERNATIONAL INC
7.2. BECTON,
DICKINSON AND COMPANY
7.3. B
BRAUN MELSUNGEN AG
7.4. CSL
LIMITED
7.5. ETHICON
INC (JOHNSON & JOHNSON)
7.6. INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
7.7. MEDTRONIC
PLC
7.8. RTI
SURGICAL
7.9. SANOFI
7.10. SMITH
& NEPHEW PLC
7.11. STRYKER
CORPORATION
7.12. WRIGHT
MEDICAL GROUP NV
7.13. ZIMMER
BIOMET HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS,
ANNOUNCEMENTS & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
& DEVELOPMENTS
TABLE 7: NORTH AMERICA
BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA
BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 3: NORTH AMERICA
BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA
BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $
MILLION)
FIGURE 6: NORTH AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $
MILLION)
FIGURE 7: NORTH AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $
MILLION)
FIGURE 8: NORTH AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SURGICAL
SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SURGICAL
SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA BIOSURGERY
MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $
MILLION)
FIGURE 14: NORTH AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA BIOSURGERY
MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA BIOSURGERY
MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA BIOSURGERY
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 18: NORTH AMERICA BIOSURGERY
MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA BIOSURGERY
MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA BIOSURGERY
MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA BIOSURGERY
MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 22: NORTH AMERICA BIOSURGERY
MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA BIOSURGERY
MARKET, BY SOURCE TYPE, 2020 & 2028 (IN %)
FIGURE 24: NORTH AMERICA BIOSURGERY
MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA BIOSURGERY
MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 26: UNITED STATES BIOSURGERY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: CANADA BIOSURGERY MARKET
2021-2028 (IN $ MILLION)